Phase I study of eniluracil, oral 5-fluororacil and gemcitabine in patients with advanced malignancy.
Morgan-Meadows S, Thomas JP, Mulkerin D, Berlin JD, Bailey H, Binger K, Volkman J, Alberti D, Feierabend C, Marrocha R, Arzoomanian RZ, Wilding G.
Morgan-Meadows S, et al. Among authors: berlin jd.
Invest New Drugs. 2002 Nov;20(4):377-82. doi: 10.1023/a:1020673928704.
Invest New Drugs. 2002.
PMID: 12448654
Clinical Trial.